Earnings Alerts

Largan Precision (3008) Earnings Surge: July Sales Soar 55% to NT$5.43 Billion

  • Record Sales in July: Largan achieved impressive July sales of NT$5.43 billion.
  • Significant Growth: Sales increased by 55% compared to previous periods.
  • Positive Analyst Ratings: Analysts’ recommendations include 21 buys, indicating strong confidence in the company’s future.
  • No Negative Sentiment: There were no sell recommendations from analysts.
  • Stable Holding: Five analysts suggest holding onto existing stocks, reflecting a sense of stability in the company’s performance.

A look at Largan Precision Smart Scores

FactorScoreMagnitude
Value3
Dividend3
Growth3
Resilience5
Momentum3
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts using the Smartkarma Smart Scores system have evaluated Largan Precision‘s long-term outlook based on key factors. With a solid overall score, Largan Precision is deemed to have good prospects. Looking at the individual scores, the company received a respectable rating for its Value, Dividend, Growth, and Momentum. However, it truly shines in terms of Resilience, scoring the highest possible rating. This indicates that the company is well-positioned to weather market fluctuations and challenges, offering investors a sense of stability and reliability.

Largan Precision Company Limited specializes in manufacturing and selling optical lens modules and optoelectronic components. Their product range includes lenses for a variety of tech products like LCD projectors, cameras, LEDs, and mobile phones, catering to a diverse market. With its balanced scores and focus on resilience, analysts view Largan Precision as a company with a promising long-term trajectory in the competitive tech industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars